We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A genetic study by MRC has suggested that combining lipoprotein lipase (LPL) enhancers with cholesterol lowering agents further reduces the risk of heart attacks than cholesterol lowering agents alone.